About CorNeat Vision
CorNeat Vision is a company based in Raanana (Israel) founded in 2015 by Gilad Litvin. CorNeat Vision has raised $4 million across 3 funding rounds from investors including European Union, GIBF and EIC Fund. CorNeat Vision offers products and services including CorNeat KPro, eShunt, and EverPatch+. CorNeat Vision operates in a competitive market with competitors including CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others.
- Headquarter Raanana, Israel
- Founders Gilad Litvin
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4 M (USD)
in 3 rounds
-
Latest Funding Round
$2.73 M (USD), Grant
Feb 01, 2022
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CorNeat Vision
CorNeat Vision offers a comprehensive portfolio of products and services, including CorNeat KPro, eShunt, and EverPatch+.
Implant for treating corneal blindness by integrating with eye tissue.
Minimally invasive drainage device for glaucoma surgery.
Permanent matrix for reinforcing ocular surfaces and repairs.
Funding Insights of CorNeat Vision
CorNeat Vision has successfully raised a total of $4M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $2.73 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CorNeat Vision
CorNeat Vision has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, GIBF and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for CorNeat Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CorNeat Vision
Investment portfolio details for CorNeat Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CorNeat Vision
Detailed financials for CorNeat Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corneat Vision Comparisons
Peer comparison for CorNeat Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CorNeat Vision
CorNeat Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CorneaGen, Satellite Bio, Avedro, EyeGate and KaloCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for corneal transplants are developed by CorneaGen.
|
|
| Locked | Locked | Locked |
Proprietary implantable satellite organs are developed for cell therapy.
|
|
| Locked | Locked | Locked |
Corneal collagen cross-linking technology is developed for ophthalmic applications.
|
|
| Locked | Locked | Locked |
Therapeutics and drug delivery systems for eye diseases are developed.
|
|
| Locked | Locked | Locked |
Nanotechnology-based red blood cell substitutes are developed.
|
|
| Locked | Locked | Locked |
iPS cell-based technology for corneal endothelium regeneration is developed.
|
Detailed competitors of CorNeat Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corneat Vision
Complete news archive for CorNeat Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CorNeat Vision
CorNeat Vision was founded in 2015 and raised its 1st funding round 6 years after it was founded.
CorNeat Vision is headquartered in Raanana, Israel. It is registered at Raanana, Central District, Israel.
Almog Aley raz is the current CEO of CorNeat Vision.
CorNeat Vision is a funded company, having raised a total of $4M across 3 funding rounds to date.
CorNeat Vision was founded in 2015 as a developer of nanotechnology-based artificial corneal implants. Nano-cell technology is employed in these synthetic corneas, which can be integrated with artificial optics. The product line, including CorNeat KPro and CorNeat EverPatch, is designed for ophthalmic surgeries addressing cornea, sclera, glaucoma trabecular mesh, myopia, and related areas. Operations focus on medical device innovation in the biotechnology sector.
CorNeat Vision offers CorNeat KPro, eShunt, and EverPatch+.
CorNeat Vision has 3 investors. Key investors include European Union, GIBF, and EIC Fund.